ID   LUPI
AC   CVCL_E5UA
SY   sample 8
RX   PubMed=8168993;
RX   PubMed=26909615;
CC   Sequence variation: Gene fusion; HGNC; HGNC:3508; EWSR1 + HGNC; HGNC:3749; FLI1; Name(s)=EWSR1-FLI1, EWS-FLI1; Note=Type 1 fusion (Ex7/Ex6) (PubMed=8168993).
CC   Caution: The relationship between sample 8 from PubMed=8168993 and LUPI from PubMed=26909615 originates from an email communication between Pfeifer, John D. and Van Tine, Brian Andrew. As this cell line is devoid of information relative to the patient from which it was derived and has no STR profile its use should be avoided.
DI   NCIt; C4817; Ewing sarcoma
DI   ORDO; Orphanet_319; Ewing sarcoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 10-04-25; Last updated: 10-04-25; Version: 1
//
RX   PubMed=8168993; DOI=10.1002/ijc.2910570308;
RA   Hamelin R., Zucman-Rossi J., Melot T., Delattre O., Thomas G.;
RT   "p53 mutations in human tumors with chimeric EWS/FLI-1 genes.";
RL   Int. J. Cancer 57:336-340(1994).
//
RX   PubMed=26909615; DOI=10.18632/oncotarget.7552; PMCID=PMC4914343;
RA   Lange S.E.S., Zheleznyak A., Studer M., O'Shannessy D.J., Lapi S.E.,
RA   Van Tine B.A.;
RT   "Development of 89Zr-Ontuxizumab for in vivo TEM-1/endosialin PET
RT   applications.";
RL   Oncotarget 7:13082-13092(2016).
//